Michael J. Burdiek
Michael J. Burdiek's purchase track record
How the stock did after each of Michael J. Burdiek's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/12/2025 | FIVN | $24K | -17.3% | -27.7% | +7.7% |
| 5/23/2025 | DCGO | $13K | +28.4% | -27.8% | +13.8% |
| 5/15/2025 | DCGO | $21K | +16.4% | -25.7% | +13.9% |
| 5/14/2024 | DCGO | $34K | +1.5% | +26.1% | +14.1% |
| 3/14/2024 | DCGO | $36K | -17.1% | -1.1% | +8.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
DocGo to hold webinar on Hicuity Health acquisition. DocGo announced an upcoming webinar to explain its vision and the details of the pending acquisition of Hicuity Health. This event provides investors with more information about a significant corporate move. The stock is currently trading near its support level, reflecting cautious sentiment ahead of the announcement.
Transaction History
| FIVN | ▲ Buy | Grant | 8,972 | $0 | 5/20/2026 | View on chart |
| DCGO | ▲ Buy | Grant | 150,000 | $0 | 12/12/2025 | View on chart |
| FIVN | ▲ Buy | Open Market | 1,000 | $24K | 8/12/2025 | View on chart |
| DCGO | ▲ Buy | Open Market | 10,000 | $13K | 5/23/2025 | View on chart |
| FIVN | ▲ Buy | Grant | 7,840 | $0 | 5/21/2025 | View on chart |
| DCGO | ▲ Buy | Open Market | 15,000 | $21K | 5/15/2025 | View on chart |
| DCGO | ▲ Buy | Grant | 34,965 | $0 | 12/13/2024 | View on chart |
| FIVN | ▲ Buy | Grant | 3,755 | $0 | 5/14/2024 | View on chart |
| DCGO | ▲ Buy | Open Market | 10,000 | $34K | 5/14/2024 | View on chart |
| DCGO | ▲ Buy | Open Market | 10,000 | $36K | 3/14/2024 | View on chart |
| DCGO | ▲ Buy | Option Exercise | 23,088 | $0 | 12/15/2023 | View on chart |
| DCGO | ▲ Buy | Grant | 32,946 | $0 | 12/12/2023 | View on chart |
| FIVN | ▲ Buy | Grant | 3,669 | $0 | 5/16/2023 | View on chart |
| DCGO | ▼ Sell | Other | 6,986 | $0 | 11/4/2022 | View on chart |
| DCGO | ▲ Buy | Grant | 97,010 | — | 9/16/2022 | View on chart |
| FIVN | ▼ Sell | Open Market | 1,234 | $142K | 8/5/2022 | View on chart |
| DCGO | ▼ Sell | Other | 415,537 | $0 | 7/27/2022 | View on chart |
| FIVN | ▲ Buy | Grant | 2,132 | $0 | 5/18/2022 | View on chart |
| DCGO | ▼ Sell | Other | 301,787 | $0 | 11/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Five9 Gains Select ISV Partner Status With NovelVox
Five9 announced that NovelVox has achieved Select ISV Partner Status to help accelerate customer experience transformation in banking, credit unions, and healthcare. This partnership aims to integrate AI-driven voice solutions into Five9's platform for specific industry needs. The stock currently trades with a high beta, indicating higher volatility relative to the broader market.
Five9 Gains Select ISV Partner Status With NovelVox. Five9 announced that NovelVox has achieved Select ISV Partner Status to help accelerate customer experience transformation in banking, credit unions, and healthcare. This partnership aims to integrate AI-driven voice solutions into Five9's platform for specific industry needs. The stock currently trades with a high beta, indicating higher volatility relative to the broader market.